ARCHIVES

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

This article is from The Cancer Letter archive.

Vol. 25 No. 22 | June 4, 1999

Download PDF Visit The Full Archive

Related Articles

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011

Letters to The Editors: Donald Coffey Finds Sensationalism Hurts

June 6, 1997

A History of NCCN

January 13, 2012

Two OAM Advisors Criticize Third over ACS Membership

July 23, 1993

Racker Withdraws Some Claims Made In Science Article, Says Data Are “No Question A Mess”

September 11, 1981

Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices

June 26, 1992